Clinical Trial Update: Regional Fatty Acid Metabolism in Humans

View source ↗

Summary

The Mayo Clinic-sponsored trial NCT00068887 investigating regional fatty acid metabolism in humans has been withdrawn. It concerns Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Mayo Clinic | Conditions: Diabetes Mellitus, Type 2 | Status: WITHDRAWN